Strontium Ranelate

Cysolvia® is one of brands under Miedykol® a high-end and certified active pharmaceutical ingredients (APIs) and pharmaceutical intermediates manufacturer in China, mainly providing various APIs products and customized production (CMO/CDMO). We produce the strontium ranelate product which was developed earlist by French company Servier and approved in multiple countries. It is a strontium (II) salt of ranelic acid, able to slow down the development of osteoarthritis of the knee, improve and strengthen intrinsic bone tissue quality and microarchitecture in osteoporosis via a number of cellular and microstructural changes so as to enhance anti-fracture efficacy. It is used for severe osteoporosis therapy, especially in high-risk adult men and postmenopausal women. At Miedykol, we produce the innovative and market much-needed active ingredient products for special disease drugs managing arrhythmia, convulsion, postmenopausal osteoporosis, etc.. We also support your healthcare project and clinical therapies with the tailored production and integrative preparation solutions. Reach out to us for further information.